Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
Clinical trial NCT07251023 · RECRUITING
Trial details
- NCT number
- NCT07251023
- Sponsor
- Bigespas LTD
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2027-05-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.